CD274 and HIV infectious disease: Longitudinal studies with the administration of anti-PD-1 or anti-PD-L1 antibodies at the time of vaccination would provide more insight into how targeting the PD-1 pathway affects the induction and longevity of vaccine-induced immunity, which is known to decay more rapidly in HIV infection.